Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

Clinical trial NCT01709435 · COMPLETED

Trial details

NCT number: NCT01709435
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Malignant Solid Neoplasm Recurrent Melanoma Recurrent Primary Central Nervous System Neoplasm Recurrent Thyroid Gland Carcinoma Refractory Malignant Solid Neoplasm Refractory Primary Central Nervous System Neoplasm Thyroid Gland Medullary Carcinoma

Start date: 2012-11-14
Primary completion: 2018-12-31
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.